Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bertram Pitt

Showing results (231-240 of 687) with videos related to

Pageof 69
Sort By:
Circulation. Heart Failure|March 20, 2010
Randomized, double-blind, multicenter, placebo-controlled study evaluating the effect of aldosterone antagonism with eplerenone on ventricular remodeling in patients with mild-to-moderate heart failure and left ventricular systolic dysfunctionJames E Udelson, Arthur M Feldman, Barry Greenberg, et al.
Journal of the American Heart Association|October 7, 2017
Sodium and Fluid Excretion With Torsemide in Healthy Subjects is Limited by the Short Duration of Diuretic ActionSalim Shah, Bertram Pitt, D Craig Brater, et al.
Circulation. Heart Failure|May 10, 2014
Incidence, predictors, and outcomes related to hypo- and hyperkalemia in patients with severe heart failure treated with a mineralocorticoid receptor antagonistOrly Vardeny, Brian Claggett, Inder Anand, et al.
European Heart Journal. Acute Cardiovascular Care|February 25, 2014
The Seattle Post Myocardial Infarction Model (SPIM): prediction of mortality after acute myocardial infarction with left ventricular dysfunctionEric S Ketchum, Kenneth Dickstein, John Kjekshus, et al.
Journal of Hypertension|November 4, 2010
Moderate versus intensive treatment of hypertension with amlodipine/valsartan for patients uncontrolled on angiotensin receptor blocker monotherapySuzanne Oparil, Thomas Giles, Elizabeth O Ofili, et al.
American Heart Journal|May 8, 2025
Loop and thiazide diuretics and outcomes in heart failure with preserved ejection fractionBarna Szabó-Söderberg, Lina Benson, Gianluigi Savarese, et al.
European Heart Journal|June 12, 2004
Haemoglobin predicts survival in patients with chronic heart failure: a substudy of the ELITE II trialRakesh Sharma, Darrel P Francis, Bertram Pitt, et al.
European Heart Journal|July 7, 2007
Cardiovascular safety of drugs not intended for cardiovascular use: need for a new conceptual basis for assessment and approvalJeffrey S Borer, Hubert Pouleur, Eric Abadie, et al.
Journal of the American Society of Hypertension : JASH|April 13, 2011
Moderate versus intensive treatment of hypertension using amlodipine/valsartan and with the addition of hydrochlorothiazide for patients uncontrolled on angiotensin receptor blocker monotherapy: results in racial/ethnic subgroupsElizabeth O Ofili, Suzanne Oparil, Thomas Giles, et al.
Blood Pressure Monitoring|March 10, 2011
The role of ambulatory blood pressure monitoring compared with clinic and home blood pressure measures in evaluating moderate versus intensive treatment of hypertension with amlodipine/valsartan for patients uncontrolled on angiotensin receptor blocker monotherapyThomas D Giles, Suzanne Oparil, Elizabeth O Ofili, et al.
Pageof 69

Showing results (231-240 of 687) with videos related to

Sort By:
Pageof 69
Circulation. Heart Failure|March 20, 2010
Randomized, double-blind, multicenter, placebo-controlled study evaluating the effect of aldosterone antagonism with eplerenone on ventricular remodeling in patients with mild-to-moderate heart failure and left ventricular systolic dysfunctionJames E Udelson, Arthur M Feldman, Barry Greenberg, et al.
Journal of the American Heart Association|October 7, 2017
Sodium and Fluid Excretion With Torsemide in Healthy Subjects is Limited by the Short Duration of Diuretic ActionSalim Shah, Bertram Pitt, D Craig Brater, et al.
Circulation. Heart Failure|May 10, 2014
Incidence, predictors, and outcomes related to hypo- and hyperkalemia in patients with severe heart failure treated with a mineralocorticoid receptor antagonistOrly Vardeny, Brian Claggett, Inder Anand, et al.
European Heart Journal. Acute Cardiovascular Care|February 25, 2014
The Seattle Post Myocardial Infarction Model (SPIM): prediction of mortality after acute myocardial infarction with left ventricular dysfunctionEric S Ketchum, Kenneth Dickstein, John Kjekshus, et al.
Journal of Hypertension|November 4, 2010
Moderate versus intensive treatment of hypertension with amlodipine/valsartan for patients uncontrolled on angiotensin receptor blocker monotherapySuzanne Oparil, Thomas Giles, Elizabeth O Ofili, et al.
American Heart Journal|May 8, 2025
Loop and thiazide diuretics and outcomes in heart failure with preserved ejection fractionBarna Szabó-Söderberg, Lina Benson, Gianluigi Savarese, et al.
European Heart Journal|June 12, 2004
Haemoglobin predicts survival in patients with chronic heart failure: a substudy of the ELITE II trialRakesh Sharma, Darrel P Francis, Bertram Pitt, et al.
European Heart Journal|July 7, 2007
Cardiovascular safety of drugs not intended for cardiovascular use: need for a new conceptual basis for assessment and approvalJeffrey S Borer, Hubert Pouleur, Eric Abadie, et al.
Journal of the American Society of Hypertension : JASH|April 13, 2011
Moderate versus intensive treatment of hypertension using amlodipine/valsartan and with the addition of hydrochlorothiazide for patients uncontrolled on angiotensin receptor blocker monotherapy: results in racial/ethnic subgroupsElizabeth O Ofili, Suzanne Oparil, Thomas Giles, et al.
Blood Pressure Monitoring|March 10, 2011
The role of ambulatory blood pressure monitoring compared with clinic and home blood pressure measures in evaluating moderate versus intensive treatment of hypertension with amlodipine/valsartan for patients uncontrolled on angiotensin receptor blocker monotherapyThomas D Giles, Suzanne Oparil, Elizabeth O Ofili, et al.
Pageof 69